Avricore Health (AVCRF) Non-Current Debt (2022)

Avricore Health (AVCRF) posted quarterly Non-Current Debt of $29468.1 for Q4 2022.

Avricore Health (AVCRF) Non-Current Debt (2022) Analysis & Trends

Avricore Health has disclosed Non-Current Debt across 1 years of filings, most recently posting $29468.1 for Q4 2022.

In Q4 2022, Non-Current Debt changed N/A year-over-year to $29468.1; the TTM figure through Dec 2022 stood at $29468.1 (changed N/A YoY), while the FY2022 annual figure was $30766.6, changed N/A from the prior year.
Non-Current Debt was little changed at $29468.1 in Q4 2022.
Over the last five years, Non-Current Debt for AVCRF reached as high as $29468.1 in Q4 2022 and fell as low as $29468.1 in Q4 2022.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn	4.86 Bn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn	40.07 Bn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn	17.56 Bn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn	299.85 Mn
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn	-
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn	-
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn	13.99 Bn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn	1.49 Bn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn	2.16 Bn
10	Avricore Health	-	-	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2022	29,468.12
Dec 31, 2022	29,468.12